Surgical management of endocarditis in drug addicts and long-term results. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Surgical management of endocarditis in drug addicts and long-term results.

J Card Surg. 1990 Mar;5(1):63-7. Unique Identifier : AIDSLINE MED/92173631
Frater RW; Albert Einstein School of Medicine Hospital, Bronx, NY 10461.


Abstract: From 1977 to May 1989, 57 successive patients who were known drug addicts with endocarditis were operated on at the Weiler Division of Montefiore Medical Center and the Albert Einstein College of Medicine. The most common lesion was aortic endocarditis. Thirty day in hospital mortality was 9%. Recurrent infection did not occur in the preAIDS era. Since the advent of HIV positive patients, failure of antibiotics to control the infection preoperatively has been seen and carries with it a severe risk of recurrent and fatal postoperative sepsis. The long-term survival was, at about 10% over 5-10 years, just good enough to warrant continued efforts in this very difficult group of patients.
Keywords: Antibiotics/THERAPEUTIC USE Endocarditis, Bacterial/DRUG THERAPY/PATHOLOGY/*SURGERY Heart Valve Prosthesis Human HIV Infections HIV Seropositivity Prognosis Prosthesis-Related Infections/SURGERY Substance Abuse, Intravenous *Substance Dependence JOURNAL ARTICLEKWDantibiotics/therapeuticuseendocarditis,bacterial/drugtherapy/pathology/KWDsurgeryheartvalveprosthesishumanhivinfectionshivseropositivityprognosisprosthesis-relatedinfections/surgerysubstanceabuse,intravenousKWDsubstancedependencejournalarticle
920630
M9260997

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .